European Patent Office Grants Biomoda Patent
The European Patent Office (EPO) has granted Biomoda, Inc.’s patent application for using our proprietary CyPath® technology to detect cancer and pre-cancerous cells in body fluid and tissue samples. Titled “Composition and Methods for Detecting Pre-Cancerous Conditions In Cell And Tissue Samples Using 5, 10, 15, 20-Tetrakis (Carboxyphenol) Porphine,” EPO patent 1364044 is similar to…
Biomoda Files New Patent Application To Optimize CyPath® Assay
Albuquerque, NM – Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath® diagnostic assay for lung cancer. “This patent is based on a proprietary solid-state, diode-based light source for fluorescent microscopy…
Shareholder Meeting
Biomoda Shareholder Presentation Meeting Results of Shareholder Meeting Proposal 1 The Company’s stockholders elected four individuals to the Board of Directors. Name VotesFor Votes Withheld John J. Cousins 162,513,010 656,872 Maria Zannes 162,800,016 369,866 Lewis White 162,619,007 550,875 David Lambros 162,619,007 550,875 Proposal 2 The Company’s stockholders…
European Patent Office To Grant Biomoda Patent
Albuquerque, NM (Aug. 2, 2011) – Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) (www.biomoda.com) received notification from the European Patent Office (EPO) of its intention to grant the company’s patent application related to a method of using Biomoda’s proprietary porphyrin-based compound to detect cancer and pre-cancerous cells in body fluid and tissue samples. “According…
Biomoda Retires Notes Early
Albuquerque, NM – Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) (www.biomoda.com) today announced that it has retired $560,000 in principal amount, plus all interest, of convertible debentures issued in September 2010. The convertible debentures were scheduled to mature on August 31, 2011. The institutional investors holding the notes completed the conversion of the notes…